相关实验视频
Updated: Jun 7, 2025

07:29
Programmed Electrical Stimulation in Mice
Published on: May 26, 2010
20.4K
在冷盐水应用期间心下鼓动值分布;探索可逆心律失常抑制
Osamu Saitoh1, Takumi Kasai1, Ayaka Oikawa1
1Cardiovascular Research of Graduate School of Health Sciences, Niigata University School of Medicine, Niigata, Japan.
Pacing and clinical electrophysiology : PACE
|November 16, 2024
概括
通过导管冷盐水灌可以暂时停止心肌信号,有助于找到射频切除的最佳地点. 这种方法对精确的心脏手术非常有前途.
科学领域:
- 心脏电生理学 心脏电生理学
- 最少侵入性心脏外科手术
- 医疗器械技术 医疗器械技术
背景情况:
- 射频 (RF) 除是心律失常的关键治疗方法.
- 精确准废除部位至关重要,特别是在微妙的心脏结构附近.
- 目前用于识别最佳除部位的方法可能需要进一步改进.
研究的目的:
- 通过灌导管来研究冷盐液应用的潜力,以可逆抑制心下肌肉刺激.
- 确定这种方法是否可以帮助识别灵敏心脏区域周围的理想射频 (RF) 能量传递点.
- 评估冷盐水对心肌刺激性的深度依赖性影响.
主要方法:
- 使用开放式灌导管将4°C盐水 (20毫升/分钟) 应用到猪心脏中.
- 测量了心肌温度在表面以下2毫米 (Temp-BS) 和节奏值增加 (%增加-PT).
- 节奏值在不同的深度被评估,使用离析导管附近的电极注入针.
主要成果:
- 冷盐水的应用可逆地抑制了心下肌肉激发,中断了心室节奏捕获.
- 节奏值的增加在心肌表面是最大的,并且随着深度的增加而减少.
- 在2-3毫米深处观察到显著的节奏值增加 (>150%),在6-7毫米深处观察到 (>120%).
结论:
- 冷盐水灌是一种简单,可逆的方法来抑制心下肌肉激发.
- 这种技术显示出在敏感心脏区域预先确定最佳除部位的潜力.
- 为了临床应用,需要进一步的研究和技术开发.
相关概念视频
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
707
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
707
Cardiac Action Potential
1.0K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
1.0K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
911
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
911
Mechanism of Cardiac Arrhythmias
891
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
891
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
782
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
782

